Both nootropic peptides grew from the Soviet neuropeptide program: ACTH and tuftsin fragments, taken to national registration in Russia.
ACTH(4-10) fragment — Pro-8-Gly-Pro. Developed at IMG RAS in the 1980-90s; registered in Russia as a medicine (drops).
Tuftsin + Pro-8-Gly-Pro. Same institute; registered in Russia, studied around anxiety models.
Unlike most research peptides, Semax and Selank have a national registration history in one country — not an international one. Elsewhere they circulate as research materials.
Dossiers: Semax (RU) · Selank (RU) · comparison — Semax vs Selank.
Registered in Russia; internationally — research materials.
Semax — ACTH fragment (neuroprotection/VND); Selank — tuftsin-derived (anxiety models).